regulatory approval and regulatory timelines), therapeutic and commercial scope and potential of such products and the costs and expenses related thereto; ?? our expectations regarding the initiation, timing and results of clinical trials of our products; ?? our expectations regarding the competitive landscape, and changes therein, related to our products, including our development